Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP CLINICAL CONFERENCE
Podcasts
Slides
Question of the Week
Donate
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
HIV Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Resources for Fellows and Others New to the HIV Field
On-Demand Webinars for Fellows
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Discrimination and Harassment Policy
Governance
Suggestions and Recommendations from San Francisco Locals
FAQs
Menu
Topics in Antiviral Medicine
™
June/July 2023
Volume 31, Issue 4
Download here
, or select individual articles
Claim CME
Selected Highlights of the 2023 Conference on Retroviruses and Opportunistic Infections (Part 2)
CROI 2023: Summary of Basic Science Research in HIV
Mario Stevenson, PhD
CROI 2023: Metabolic and Other Complications of HIV Infection
Sudipa Sarkar, MD, Todd T. Brown, MD, PhD
CROI 2023: Tuberculosis and Infectious Complications in Persons With HIV
Andrew D. Kerkhoff, MD, PhD, MSc, Diane V. Havlir, MD
CROI 2023: Neuropsychiatric Complications in People With HIV
Albert M. Anderson, MD, Beau M. Ances, MD, PhD, Scott L. Letendre, MD
Topics in Antiviral Medicine™
Current Issues
Previous Issues
TAM
Policies and Practices
TAM
Author and Contributor Guidelines
Topics in Antiviral Medicine
Editorial Board
CROI
Conference on Bacteriophages
RWHAP CLINICAL CONFERENCE
Podcasts
Slides
Question of the Week
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
HIV Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Resources for Fellows and Others New to the HIV Field
On-Demand Webinars for Fellows
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Discrimination and Harassment Policy
Governance
Suggestions and Recommendations from San Francisco Locals
FAQs
Practice Question of the Week
February 2, 2026: Preexposture Prophylaxis Management After Bariatric Surgery
As a member of a national preexposure prophylaxis (PrEP) guideline committee, you are asked to include a paragraph about PrEP in individuals who have had bariatric surgery. Which of the following do you advise?
A. Oral PrEP with tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) is not an option due to insufficient absorption of TDF/FTC
B. Oral PrEP with tenofovir alafenamide (TAF)/FTC is preferred over oral PrEP with TDF/FTC
C. Daily PrEP with TDF/FTC is an option, but on-demand PrEP with TDF/FTC cannot be recommended
D. Individuals who have had bariatric surgery should receive parenteral PrEP (eg, injectable cabotegravir [CAB] or lenacapavir [LEN])
View the On-Demand Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE
